This post is intended for my friends and family, not for general distribution.
There is truly exciting breaking news for cancer screening. It’s called a Grail.
It is a new technology called “liquid biopsy” that is done via a blood test. It is just now becoming established and has limited FDA approval. It is available only at a few locations.
The Grail is a quick and simple test which costs about $1,000 (insurance doesn’t cover it), and remarkably, it has the potential to detect over 50 cancer types, 45 of which do not currently have any recommended screening. Not only can it detect incipient cancer, it can identify with 90% accuracy what part of the body the cancer originates from.
This is really on the order of an announcement rather than attempting to describe it. If you truly are interested in this, just send me a brief message and I’ll forward the report (which I got from my longevity clinic) to you.
After writing this, I read on Thursday, June 3, an article in the Wall Street Journal which said:
“Grails technology can now reliably detect 50 cancers at early stages with a simple blood draw… false positives rate is less than 1%, which is lower than for mammograms and PSA prostate tests. Grail technology can also detect the 12 most deadly cancers with 60% accuracy, and has the potential to reduce false cancer diagnoses and invasive screenings while increasing early detection for aggressive cancers.”